Hey-Mogensen Martin, Goncalves Renata L S, Orr Adam L, Brand Martin D
Buck Institute for Research on Aging, Novato, CA 94945, USA; Department of Biomedical Sciences, Center for Healthy Aging, Copenhagen University, Copenhagen, Denmark.
Buck Institute for Research on Aging, Novato, CA 94945, USA.
Free Radic Biol Med. 2014 Jul;72:149-55. doi: 10.1016/j.freeradbiomed.2014.04.007. Epub 2014 Apr 16.
Dehydrogenases that use ubiquinone as an electron acceptor, including complex I of the respiratory chain, complex II, and glycerol-3-phosphate dehydrogenase, are known to be direct generators of superoxide and/or H2O2. Dihydroorotate dehydrogenase oxidizes dihydroorotate to orotate and reduces ubiquinone to ubiquinol during pyrimidine metabolism, but it is unclear whether it produces superoxide and/or H2O2 directly or does so only indirectly from other sites in the electron transport chain. Using mitochondria isolated from rat skeletal muscle we establish that dihydroorotate oxidation leads to superoxide/H2O2 production at a fairly high rate of about 300pmol H2O2·min(-1)·mg protein(-1) when oxidation of ubiquinol is prevented and complex II is uninhibited. This H2O2 production is abolished by brequinar or leflunomide, known inhibitors of dihydroorotate dehydrogenase. Eighty percent of this rate is indirect, originating from site IIF of complex II, because it can be prevented by malonate or atpenin A5, inhibitors of complex II. In the presence of inhibitors of all known sites of superoxide/H2O2 production (rotenone to inhibit sites in complex I (site IQ and, indirectly, site IF), myxothiazol to inhibit site IIIQo in complex III, and malonate plus atpenin A5 to inhibit site IIF in complex II), dihydroorotate dehydrogenase generates superoxide/H2O2, at a small but significant rate (23pmol H2O2·min(-1)·mg protein(-1)), from the ubiquinone-binding site. We conclude that dihydroorotate dehydrogenase can generate superoxide and/or H2O2 directly at low rates and is also capable of indirect production at higher rates from other sites through its ability to reduce the ubiquinone pool.
以泛醌作为电子受体的脱氢酶,包括呼吸链复合体I、复合体II和甘油-3-磷酸脱氢酶,已知是超氧化物和/或过氧化氢的直接产生者。二氢乳清酸脱氢酶在嘧啶代谢过程中将二氢乳清酸氧化为乳清酸,并将泛醌还原为泛醇,但尚不清楚它是直接产生超氧化物和/或过氧化氢,还是仅通过电子传递链中的其他位点间接产生。利用从大鼠骨骼肌分离的线粒体,我们发现,当泛醇的氧化被阻止且复合体II未受抑制时,二氢乳清酸氧化会以约300pmol过氧化氢·分钟⁻¹·毫克蛋白质⁻¹的相当高的速率导致超氧化物/过氧化氢的产生。这种过氧化氢的产生可被二氢乳清酸脱氢酶的已知抑制剂布雷喹那或来氟米特消除。该速率的80%是间接产生的,源自复合体II的位点IIF,因为它可被复合体II的抑制剂丙二酸或阿替普宁A5阻止。在所有已知的超氧化物/过氧化氢产生位点的抑制剂(鱼藤酮抑制复合体I中的位点(位点IQ以及间接抑制位点IF)、粘噻唑抑制复合体III中的位点IIIQo、丙二酸加阿替普宁A5抑制复合体II中的位点IIF)存在的情况下,二氢乳清酸脱氢酶会从泛醌结合位点以较小但显著的速率(23pmol过氧化氢·分钟⁻¹·毫克蛋白质⁻¹)产生超氧化物/过氧化氢。我们得出结论,二氢乳清酸脱氢酶能够以低速率直接产生超氧化物和/或过氧化氢,并且还能够通过其还原泛醌池的能力从其他位点以较高速率间接产生。